A detailed history of Shay Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Shay Capital LLC holds 505 shares of LLY stock, worth $376,831. This represents 0.07% of its overall portfolio holdings.

Number of Shares
505
Holding current value
$376,831
% of portfolio
0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $389,930 - $484,810
505 New
505 $447,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $355,320 - $475,368
600 Added 100.0%
1,200 $933,000
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $220,579 - $260,034
-420 Reduced 41.18%
600 $349,000
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $443,394 - $611,286
1,020 New
1,020 $547,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $419,350 - $492,507
1,350 New
1,350 $463,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $296,480 - $337,870
1,000 New
1,000 $323,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Shay Capital LLC Portfolio

Follow Shay Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shay Capital LLC with notifications on news.